About Index Trending news
Analyze
Top 50 Pricing
Chimerix

Chimerix

Work at Chimerix? Add yourself to this profile

Chimerix

Developing important antiviral medicines for the treatment of life-threatening diseases. $CMRX

Elsewhere

Alexa global traffic share

Twitter followers

Latest funding Show all
Post-IPO equity
$122,000,000
Venture capital (Series F)
$45,000,000
Employees

Team size

50+
Locations
HQ
Headquarters
Xconomy

Chimerix, TransEnterix, BDSI, Duke Energy & More NC Innovation News

The Motley Fool

Here's Why Chimerix Inc Jumped 14.3% in April

Xconomy

Precision BioSciences, Chimerix, Spreedly, & More NC Innovation News

Health Funding
Xconomy

After Failed Trial, Chimerix Shuts Down Two More Phase 3 Tests

The Motley Fool

Chimerix Inc. Is Roaring Higher Again -- Here's Why --

Stock markets
The Motley Fool

Why Chimerix Inc. Is Up Big Today --

Stock markets Health
Xconomy

Chimerix, DeSimone, Merz, & More in NC Innovation News

Funding Health
The Motley Fool

Why Valeant Pharmaceuticals, Chimerix, and 3D Systems Slumped Today --

Stock markets Health
The Motley Fool

Why Chimerix's Shares Collapsed Today --

Stock markets Health
Xconomy

Chimerix Stock Plunges After Anti-Infection Drug Fails Phase 3 Trial